[April 27, 2015] |
|
PHT Corporation Selects Hewlett Packard ElitePad 1000 with Windows 8.1 for SitePad® System in eClinical Research
PHT
Corporation announced the selection of the Hewlett Packard (HP)
ElitePad 1000 G2 (News - Alert) with Windows 8.1 for its SitePad®
System. The SitePad System replaces paper data collection methods in
clinical trials that collect clinician- and patient-reported outcomes
for supporting label claims of new drugs. PHT is the leading provider of
mobile apps used to collect patient-driven
eData for clinical research.
The SitePad System is used to collect clinician-driven endpoints such as
disease progression, impression and assessments as well as patient
reported outcomes and quality of life data directly from patients. The
SitePad is configured to the requirements of clinical protocols and the
study specific data collected is sent securely to StudyWorks™,
the PHT online portal that provides real-time information about study
compliance plus key measures used for operations and patient safety
monitoring. Protocol compliance with the SitePad System exceeds 98.5%
historicaly over 130 trials.
Demand for the PHT SitePad System has been growing steadily in recent
years across therapeutic areas including oncology, immunology, and CNS.
Clients are using the SitePad to increase the quality and efficiency of
both patient and clinician reported outcomes across indications and do
not want paper to be a rate limiting step in the clinical trial process.
The SitePad System delivers higher quality data and faster time to data
analysis for clinical trial sponsors. Watch a brief video: http://bit.ly/1cpCXcl
Sheila Rocchio, PHT Vice President of Marketing and Corporate Strategy,
commented, "Sponsors and CROs rely on the SitePad System for trials of
all types because it offers a reliable, easy-to-use and regulatory
compliant method for increasing data quality and protocol compliance.
The SitePad System supports risked based monitoring strategies by
providing real-time access to endpoint data and has been proven to
significantly reduce monitoring and data management costs. In a recent
Phase III trial, using the SitePad was 30% more cost effective than
using paper."
The HP ElitePad 1000 G2 contains an Intel (News - Alert)® 64-bit Atom processor. It
weighs 1.5 lbs. and is one of the thinnest tablets in the industry, at
9.2 mm. Features include wider viewing angles on the outdoor-viewable
10.1-inch diagonal WUXGA multi-touch panel; wireless connection,
including optional worldwide 4G LTE (News - Alert) with HP Connection Manager; and,
support for touch, pen or voice-based input. The HP ElitePad 1000 G2
offers enhanced protection against virus attack, with a design that
helps prevent data loss and reduce downtime.
Learn how Celgene Corporation used the SitePad System to save $13
million: http://www.phtcorp.com/PHT-Celgene-Case-Study-HPPR.aspx
About PHT Corporation
PHT Corporation is the eClinical innovator leading the adoption of
patient-driven mobile apps for improved clinical research. Visit phtcorp.com for
more information on PHT. Follow PHT on LinkedIn, Facebook, Twitter, Google+ and YouTube.
[ Back To Mobile World Congress's Homepage ]
|